Literature DB >> 35904143

Hospital Diabetes Meeting 2022.

Jingtong Huang1, Andrea M Yeung1, Kevin T Nguyen1, Nicole Y Xu1, Jean-Charles Preiser2, Robert J Rushakoff3, Jane Jeffrie Seley4, Guillermo E Umpierrez5, Amisha Wallia6, Andjela T Drincic7, Roma Gianchandani8, M Cecilia Lansang9, Umesh Masharani3, Nestoras Mathioudakis10, Francisco J Pasquel5, Signe Schmidt11, Viral N Shah12, Elias K Spanakis13, Andreas Stuhr1, Gerlies M Treiber14, David C Klonoff15.   

Abstract

The annual Virtual Hospital Diabetes Meeting was hosted by Diabetes Technology Society on April 1 and April 2, 2022. This meeting brought together experts in diabetes technology to discuss various new developments in the field of managing diabetes in hospitalized patients. Meeting topics included (1) digital health and the hospital, (2) blood glucose targets, (3) software for inpatient diabetes, (4) surgery, (5) transitions, (6) coronavirus disease and diabetes in the hospital, (7) drugs for diabetes, (8) continuous glucose monitoring, (9) quality improvement, (10) diabetes care and educatinon, and (11) uniting people, process, and technology to achieve optimal glycemic management. This meeting covered new technology that will enable better care of people with diabetes if they are hospitalized.

Entities:  

Keywords:  continuous glucose monitor; diabetes; electronic health record; hospital; insulin; technology

Mesh：

Substances：

Year:  2022        PMID： 35904143      PMCID： PMC9445340          DOI： 10.1177/19322968221110878

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN： 1932-2968


  69 in total

Review 1.  Management of Type 1 Diabetes in the Hospital Setting.

Authors:  Carlos E Mendez; Guillermo E Umpierrez
Journal:  Curr Diab Rep       Date:  2017-09-14       Impact factor: 4.810

2.  Association of Glucose Concentrations at Hospital Discharge With Readmissions and Mortality: A Nationwide Cohort Study.

Authors:  Elias K Spanakis; Guillermo E Umpierrez; Tariq Siddiqui; Min Zhan; Soren Snitker; Jeffrey C Fink; John D Sorkin
Journal:  J Clin Endocrinol Metab       Date:  2019-09-01       Impact factor: 5.958

3.  Comparative Accuracy of 17 Point-of-Care Glucose Meters.

Authors:  Laya Ekhlaspour; Debbie Mondesir; Norman Lautsch; Courtney Balliro; Mallory Hillard; Kendra Magyar; Laura Goergen Radocchia; Aryan Esmaeili; Manasi Sinha; Steven J Russell
Journal:  J Diabetes Sci Technol       Date:  2016-10-03

4.  Continuous Glucose Monitors and Automated Insulin Dosing Systems in the Hospital Consensus Guideline.

Authors:  Rodolfo J Galindo; Guillermo E Umpierrez; Robert J Rushakoff; Ananda Basu; Suzanne Lohnes; James H Nichols; Elias K Spanakis; Juan Espinoza; Nadine E Palermo; Dessa Garnett Awadjie; Leigh Bak; Bruce Buckingham; Curtiss B Cook; Guido Freckmann; Lutz Heinemann; Roman Hovorka; Nestoras Mathioudakis; Tonya Newman; David N O'Neal; Michaela Rickert; David B Sacks; Jane Jeffrie Seley; Amisha Wallia; Trisha Shang; Jennifer Y Zhang; Julia Han; David C Klonoff
Journal:  J Diabetes Sci Technol       Date:  2020-09-28

Review 5.  The use of sodium-glucose co-transporter 2 inhibitors in the inpatient setting: Is the risk worth taking?

Authors:  Theocharis Koufakis; Omar G Mustafa; Ramzi A Ajjan; Xavier Garcia-Moll; Pantelis Zebekakis; George Dimitriadis; Kalliopi Kotsa
Journal:  J Clin Pharm Ther       Date:  2020-01-06       Impact factor: 2.512

6.  Controversies Around the Measurement of Blood Ketones to Diagnose and Manage Diabetic Ketoacidosis.

Authors:  Eric S Kilpatrick; Alexandra E Butler; Linda Ostlundh; Stephen L Atkin; David B Sacks
Journal:  Diabetes Care       Date:  2022-02-01       Impact factor: 19.112

7.  Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: A Meta-analysis.

Authors:  Darren K McGuire; Weichung J Shih; Francesco Cosentino; Bernard Charbonnel; David Z I Cherney; Samuel Dagogo-Jack; Richard Pratley; Michelle Greenberg; Shuai Wang; Susan Huyck; Ira Gantz; Steven G Terra; Urszula Masiukiewicz; Christopher P Cannon
Journal:  JAMA Cardiol       Date:  2021-02-01       Impact factor: 14.676

8.  Continuous Glucose Monitoring in the Intensive Care Unit During the COVID-19 Pandemic.

Authors:  Shivani Agarwal; Justin Mathew; Georgia M Davis; Alethea Shephardson; Ann Levine; Rita Louard; Agustina Urrutia; Citlalli Perez-Guzman; Guillermo E Umpierrez; Limin Peng; Francisco J Pasquel
Journal:  Diabetes Care       Date:  2020-12-23       Impact factor: 19.112

Review 9.  Managing Patients with Insulin Pumps and Continuous Glucose Monitors in the Hospital: to Wear or Not to Wear.

Authors:  Tiffany Yeh; Michele Yeung; Felicia A Mendelsohn Curanaj
Journal:  Curr Diab Rep       Date:  2021-01-15       Impact factor: 4.810

10.  The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial.

Authors:  Adriaan A Voors; Christiane E Angermann; John R Teerlink; Sean P Collins; Mikhail Kosiborod; Jan Biegus; João Pedro Ferreira; Michael E Nassif; Mitchell A Psotka; Jasper Tromp; C Jan Willem Borleffs; Changsheng Ma; Joseph Comin-Colet; Michael Fu; Stefan P Janssens; Robert G Kiss; Robert J Mentz; Yasushi Sakata; Henrik Schirmer; Morten Schou; P Christian Schulze; Lenka Spinarova; Maurizio Volterrani; Jerzy K Wranicz; Uwe Zeymer; Shelley Zieroth; Martina Brueckmann; Jonathan P Blatchford; Afshin Salsali; Piotr Ponikowski
Journal:  Nat Med       Date:  2022-02-28       Impact factor: 53.440
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.